WEED Stock Overview
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Canopy Growth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$4.04 |
| 52 Week High | CA$20.50 |
| 52 Week Low | CA$3.74 |
| Beta | 1.71 |
| 1 Month Change | -23.34% |
| 3 Month Change | -36.38% |
| 1 Year Change | -40.68% |
| 3 Year Change | -96.78% |
| 5 Year Change | -98.39% |
| Change since IPO | -84.40% |
Recent News & Updates
Recent updates
Canopy Growth Corporation (TSE:WEED) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Nov 05
More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 26%
Aug 28We Think Canopy Growth (TSE:WEED) Has A Fair Chunk Of Debt
Aug 17Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%
Jun 15Canopy Growth Corporation's (TSE:WEED) 77% Share Price Surge Not Quite Adding Up
Apr 20More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%
Feb 23Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report
Feb 13Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge
Dec 22Is Canopy Growth (TSE:WEED) A Risky Investment?
Sep 17With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For
Apr 17Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Mar 21Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 12Shareholder Returns
| WEED | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -8.6% | -0.5% | -2.6% |
| 1Y | -40.7% | -26.9% | 15.2% |
Return vs Industry: WEED underperformed the Canadian Pharmaceuticals industry which returned -26.9% over the past year.
Return vs Market: WEED underperformed the Canadian Market which returned 15.2% over the past year.
Price Volatility
| WEED volatility | |
|---|---|
| WEED Average Weekly Movement | 11.5% |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 17.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: WEED has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: WEED's weekly volatility has decreased from 21% to 12% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,029 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices.
Canopy Growth Corporation Fundamentals Summary
| WEED fundamental statistics | |
|---|---|
| Market cap | CA$410.90m |
| Earnings (TTM) | -CA$585.69m |
| Revenue (TTM) | CA$280.50m |
1.5x
P/S Ratio-0.7x
P/E RatioIs WEED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WEED income statement (TTM) | |
|---|---|
| Revenue | CA$280.50m |
| Cost of Revenue | CA$193.61m |
| Gross Profit | CA$86.89m |
| Other Expenses | CA$672.58m |
| Earnings | -CA$585.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.56 |
| Gross Margin | 30.98% |
| Net Profit Margin | -208.81% |
| Debt/Equity Ratio | 108.7% |
How did WEED perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 09:55 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Canopy Growth Corporation is covered by 30 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Capital Markets |
| Gaurav Jain | Barclays |